朸浚国际(01355) - 2025 - 中期财报

CORPORATE INFORMATION Directors and Committee Composition The company's board of directors comprises executive, non-executive, and independent non-executive directors, supported by audit, nomination, and remuneration committees to ensure robust corporate governance - Executive Director is Ms. Li Zhi Xin[3] - Non-executive Directors include Chairman Mr. Yuan Fuaer and Mr. Hu Xinglong[3] - Independent Non-executive Directors include Mr. Wu Jilin (Audit Committee Chairman), Mr. Lin Changsheng (Nomination Committee Chairman), and Mr. Su Yanwei (Remuneration Committee Chairman)[3][4] Company Details The company's principal bankers include Industrial Bank in China and Hang Seng Bank, Bank of China (Hong Kong), and Bank of Communications (Hong Kong) in Hong Kong, with auditors being National Alliance CPA Limited and stock code 1355 - Principal bankers include Industrial Bank Co., Ltd. in China, and Hang Seng Bank Limited, Bank of China (Hong Kong) Limited, and Bank of Communications (Hong Kong) Limited in Hong Kong[5][6] - Auditor is National Alliance CPA Limited[6][7] - Company stock code is 1355, website is **www.legend-strategy.com**[8](index=8&type=chunk)[9] MANAGEMENT DISCUSSION AND ANALYSIS Business Review The Group primarily operates accommodation and healthcare and beauty businesses, with accommodation revenue declining by 28.9% due to global instability, while healthcare and beauty contributed approximately HKD 11,886,000 in revenue - The Group primarily engages in accommodation business (including accommodation operation, property facilities management, and accommodation consulting services) and healthcare and beauty business[10][12] - For the six months ended June 30, 2025, the Group operated five leased accommodation projects[10][12] Accommodation Business Accommodation business revenue decreased by 28.9% year-on-year due to global economic instability and geopolitical conflicts, with the Nanshan store closure generating approximately HKD 1,920,000 in early lease termination income - The hotel business continues to be affected by global economic instability and geopolitical conflicts, particularly China's economic slowdown and weakened consumer sentiment[11][13] - The Group adopts flexible sales and marketing strategies to improve existing accommodation project performance and promotes sustainable high-quality corporate development through enhanced management, cost control, and expense reduction[11][13] Accommodation Operation and Property Facilities Management Accommodation operation and property facilities management revenue was approximately HKD 13,579,000, a 28.9% year-on-year decrease, primarily due to lower occupancy rates and reduced consulting service income in China's hotel market Accommodation Operation and Property Facilities Management Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | Change Rate | | :--- | :--- | :--- | :--- | | Revenue | 13,579,000 | 19,104,000 | -28.9% | - Revenue decrease primarily attributed to lower occupancy rates due to declining overall market sentiment in China's hotel industry, and reduced accommodation consulting service income[14][18] - The Group enhances customer loyalty by collaborating with new travel intermediaries, updating sales strategies, offering preferential pricing models, deepening understanding of customer needs, and providing customized services[16][19] Branch Performance Overview The Group's accommodation branches employ flexible strategies, with Chengdu benefiting from tourism recovery, Wuhan operating steadily, Huizhou anticipating Greater Bay Area growth, Nanshan generating HKD 1,920,000 from lease termination, and Bao'an maintaining stability through cost control - The Chengdu store, located in the prime Tianfu Square business district, benefits from Chengdu's economic recovery and rebound in tourism consumer confidence, expecting sustained stable income in the future[20][21][22] - The Wuhan store, a transportation hub, experienced a slight demand decrease due to domestic economic development difficulties but achieved expected results in adversity through strengthened management, marketing, and cost optimization[23][24][26] - The Huizhou store, focusing on the resort tourism market, anticipates that Greater Bay Area development and international projects (such as Shenzhen East Legoland Theme Park) will drive tourist growth and long-term performance improvement[25][27][28][32] - The Nanshan store ceased operations due to property repossession by the landlord for redevelopment, with approximately HKD 1,920,000 in early lease termination income recognized this period[30][33] - The Bao'an store maintained stable operating performance in adversity, benefiting from effective cost control and sales strategies[34][35][40] Accommodation Consulting Services Accommodation consulting services generated zero revenue this period, a significant decline from the prior year, leading the Group to reduce marketing investment and reallocate resources to the more promising healthcare and beauty business Accommodation Consulting Services Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | | :--- | :--- | :--- | | Revenue | 0 | 1,126,000 | - Given the reduced demand for such services, the Group will decrease marketing investment to save operating costs and reallocate resources to the healthcare and beauty business segment[37][41] Healthcare and Beauty Business The Group, through its wholly-owned subsidiary Shenzhen Yalansi Biotechnology Co. Ltd., generated approximately HKD 11,886,000 in revenue this period by directly selling and promoting own-brand and third-party healthcare and beauty products in China - The Group will continue to develop its healthcare and beauty business through collaborations with key industry players and the development of proprietary rights and technologies[38][42] Healthcare and Beauty Business Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | | :--- | :--- | :--- | | Revenue | 11,886,000 | 0 | - During this period, this business generated approximately HKD 11,886,000 in revenue by directly selling and promoting own-brand products in China through Shenzhen Yalansi Biotechnology Co. Ltd.[39][42] Outlook The Group plans to expand its market share in China's healthcare and beauty sector and explore international sales, considering an equity acquisition of an R&D platform for technology and competitive advantage, though no final agreement has been reached - The Group will further develop and strengthen its market share in China's healthcare and beauty industry and seek opportunities to expand sales to other regions[44][47] - The Group is considering acquiring an equity interest in an R&D platform to gain cutting-edge technology and maintain a competitive advantage[44][47] - As of the date of this interim report, no decision has been made or final agreement reached regarding the potential acquisition, and shareholders and potential investors are urged to exercise caution[45][47] Financial Review The Group's revenue increased by 33.2% to approximately HKD 25,445,000 this period, driven by healthcare and beauty, but a decline in accommodation revenue and non-financial asset impairment led to a HKD 13,484,000 loss attributable to owners Overall Financial Performance The Group's revenue reached approximately HKD 25,445,000, a 33.2% year-on-year increase, but reduced accommodation income and a HKD 8,340,000 non-financial asset impairment resulted in a HKD 13,484,000 loss attributable to owners, compared to a prior year profit of HKD 3,211,000 Key Financial Indicators | Metric | H1 2025 (HKD) | H1 2024 (HKD) | Change Rate | | :--- | :--- | :--- | :--- | | Revenue | 25,445,000 | 19,104,000 | +33.2% | | Loss/(Profit) Attributable to Owners | (13,4